Clinical Trial to Evaluate the Tolerance of TQB3201 Tablets

NCT07172126 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

291

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Castration-resistant Prostate Cancer

Interventions

DRUG: TQB3201 tablets

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.